WHO ICTRP trial
A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and…
PACTR202209604592389 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202209604592389 |
|---|---|
| Public title | A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease |
| Scientific title | A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell Disease |
| Primary sponsor | Forma Therapeutics Inc |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-2 |
| Countries | Nigeria;Nigeria;Kenya;Kenya;Kenya;Nigeria |
| Conditions | Haematological Disorders;Haematological Disorders |
| Interventions | Etavopivat;Etavopivat |
| Registration date | May 17, 2022 |
| Target size | 50 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: